EC
ARRY

EcoR1 Capital’s Array Biopharma Inc ARRY Stock Holding History

EcoR1 Capital’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-644,002
Closed -$9.18M – 60
2018
Q4 		$9.18M Buy
+644,002
New +$9.77M 0.92% 34
2018
Q2 		– Sell
-3,049,312
Closed -$49.8M – 48
2018
Q1 		$49.8M Buy
3,049,312
+166,600
+6% +$2.67M 4.99% 7
2017
Q4 		$36.9M Buy
2,882,712
+1,632,712
+131% +$18.6M 4.15% 8
2017
Q3 		$15.4M Buy
+1,250,000
New +$11.6M 2.05% 12
2015
Q3 		– Sell
-400,000
Closed -$2.88M – 31
2015
Q2 		$2.88M Buy
+400,000
New +$2.95M 0.96% 18

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

EcoR1 Capital's ARRY Position: Q1 2019 in Review

EcoR1 Capital sold out of Array Biopharma Inc (ARRY) in Q1 2019, closing a stake of 644,002 shares — an estimated $9.18M sold.

EcoR1 Capital first reported a position in ARRY in Q2 2015 and held it in 5 quarters. The position peaked at $49.8M in Q1 2018. 268 funds tracked by Wall St. Rank hold ARRY as of Q1 2019.

  • EcoR1 Capital reported no remaining Array Biopharma Inc position as of Q1 2019 after selling out during the quarter.
  • EcoR1 Capital sold 644,002 Array Biopharma Inc shares in Q1 2019, an estimated $9.18M.
  • EcoR1 Capital first reported a position in Array Biopharma Inc in Q2 2015 and held it in 5 quarters.
  • EcoR1 Capital's Array Biopharma Inc position peaked at $49.8M in Q1 2018.
  • 268 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2019.

Based on EcoR1 Capital's 13F filing for Q1 2019, filed 15 May 2019.